Related Experiment Video

Updated: Jun 28, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Polymyalgia rheumatica and its links with giant cell arteritis

Rodger Charlton1

  • 1Institute of Clinical Education, The Medical School, University of Warwick, Coventry. rodger.charlton@warwick.ac.uk

Clinical Medicine (London, England)
|November 4, 2008
PubMed

Insights

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) affect older adults and are diagnosed clinically. Research is ongoing to improve diagnosis and treatment for these inflammatory conditions.

Area of Science:

  • Rheumatology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a clinical diagnosis often associated with giant cell arteritis (GCA).
  • PMR incidence increases with age, affecting individuals typically between 60 and 75 years old.
  • A definitive diagnostic test for PMR is lacking, making differential diagnosis challenging.

Purpose of the Study:

  • To review the current understanding of polymyalgia rheumatica (PMR) and its overlap with giant cell arteritis (GCA).
  • To discuss diagnostic challenges and current treatment approaches for PMR and GCA.
  • To highlight areas requiring further research in PMR and GCA.

Main Methods:

  • Literature review of PMR and GCA definitions, incidence, diagnosis, and treatment.
  • Analysis of the relationship between PMR and GCA, including diagnostic criteria and management strategies.
  • Discussion of clinical presentation and therapeutic responses to corticosteroids.

Main Results:

  • PMR diagnosis is clinical, with GCA occurring in about 25% of PMR cases.
  • Corticosteroid treatment is standard, with initial doses of 10-20 mg/day for PMR and 40-60 mg/day if GCA is suspected.
  • Prompt steroid initiation is crucial for GCA with suspected temporal arteritis to prevent blindness.

Conclusions:

  • PMR and GCA remain challenging conditions due to diagnostic complexities and evolving treatment guidelines.
  • Further research is needed to elucidate the cause, refine diagnostic methods, and optimize treatment for PMR and its GCA overlap.
  • Effective management requires individualized corticosteroid tapering based on patient response.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...